DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Clinical trials for DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) trials appear
Sign up with your email to follow new studies for DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental Dual-Targeting CAR t therapy for lymphoma shows early promise but trial halted
Disease control TerminatedThis early-phase study tested a new treatment called bbT369 for people with a type of blood cancer (B cell non-Hodgkin's lymphoma) that had come back or stopped responding to standard treatments. The therapy uses a patient's own immune cells, which are modified in a lab to better…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New antibody drug for tough blood cancers shows early promise but trial halted
Disease control TerminatedThis study tested a new antibody drug called GEN3014 in people with multiple myeloma or other blood cancers that had come back or stopped responding to treatment. The main goal was to check the drug's safety and find the best dose. The trial was stopped early, but the results hel…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Experimental drug combo targets tough blood cancers
Disease control TerminatedThis early-phase study tested a new drug called voruciclib, alone or combined with another drug (venetoclax), in adults with certain blood cancers (like lymphoma or leukemia) that returned or didn't respond to standard treatments. The main goal was to check safety and find the ri…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Phase: PHASE1 • Sponsor: MEI Pharma, Inc. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC